Daniel Thomas-Lopez

Daniel Thomas-Lopez

Auto-generated profile, based on publicly available information

Daniel Thomas-Lopez

European Public Health Microbiology Training Programme (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Cell Metabolism
Verified
Journal Article
Closed access
JZJasmina Zivanovic
Jasmina Zivanovic
EKEmilia Kouroussis
Emilia Kouroussis
JKJoshua B. Kohl
Joshua B. Kohl
BABikash Adhikari
Bikash Adhikari
BBBiljana Bursac
Biljana Bursac
Milos R. FilipovicMilos R. Filipovic
Milos R. Filipovic

14 July 2022 in Eurosurveillance
Verified
Journal Article
Open access
EAEttore Amato
Ettore Amato
MRMaximilian Riess
Maximilian Riess
DTDaniel Thomas-Lopez
Daniel Thomas-Lopez
MLMarius Linkevicius
Marius Linkevicius
TPTarja Pitkänen
Tarja Pitkänen
UNUmaer Naseer
Umaer Naseer
Background: Vibriosis cases in Northern European countries and countries bordering the Baltic Sea increased during heatwaves in 2014 and 2018. Aim: We describe the epidemiology of vibriosis and the genetic diversity of Vibrio spp. isolates from Norway, Sweden, Denmark, Finland, Poland and Estonia in 2018, a year with an exceptionally warm summer. Methods: In a retrospective study, we analysed demographics, geographical distribution, seasonality, causative species and severity of non-travel-related vibriosis cases in 2018. Data sources included surveillance systems, national laboratory notification databases and/or nationwide surveys to public health microbiology laboratories. Moreover, we performed whole genome sequencing and multilocus sequence typing of available isolates from 2014 to 2018 to map their genetic diversity. Results: In 2018, we identified 445 non-travel-related vibriosis cases in the study countries, considerably more than the median of 126 cases between 2014 and 2017 (range: 87–272). The main reported mode of transmission was exposure to seawater. We observed a species-specific geographical disparity of vibriosis cases across the Nordic-Baltic region. Severe vibriosis was associated with infections caused by Vibrio vulnificus (adjOR: 17.2; 95% CI: 3.3–90.5) or Vibrio parahaemolyticus (adjOR: 2.1; 95% CI: 1.0–4.5), age ≥ 65 years (65–79 years: adjOR: 3.9; 95% CI: 1.7–8.7; ≥ 80 years: adjOR: 15.5; 95% CI: 4.4–54.3) or acquiring infections during summer (adjOR: 5.1; 95% CI: 2.4–10.9). Although phylogenetic analysis revealed diversity between Vibrio spp. isolates, two V. vulnificus clusters were identified. Conclusion: Shared sentinel surveillance for vibriosis during summer may be valuable to monitor this emerging public health issue.

1 September 2013 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
LHLaura Hidalgo
Laura Hidalgo
BGBelen Gutierrez
Belen Gutierrez
COCristina M. Ovejero
Cristina M. Ovejero
LCLaura Carrilero
Laura Carrilero
SMStephanie Matrat
Stephanie Matrat
BGBruno Gonzalez-Zorn
Bruno Gonzalez-Zorn
Seven Klebsiella pneumoniae isolates from dogs and cats in Spain were found to be highly resistant to aminoglycosides, and ArmA methyltransferase was responsible for this phenotype. All isolates were typed by multilocus sequence typing (MLST) as ST11, a human epidemic clone reported worldwide and associated with, among others, OXA-48 and NDM carbapenemases. In the seven strains, armA was borne by an IncR plasmid, pB1025, of 50 kb. The isolates were found to coproduce DHA-1 and SHV-11 β-lactamases, as well as the QnrB4 resistance determinant. This first report of the ArmA methyltransferase in pets illustrates their importance as a reservoir for human multidrug-resistant K. pneumoniae .

1 May 2012 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
BGBelen Gutierrez
Belen Gutierrez
JEJose Antonio Escudero
Jose Antonio Escudero
AMAlvaro San Millan
Alvaro San Millan
LHLaura Hidalgo
Laura Hidalgo
LCLaura Carrilero
Laura Carrilero
BGBruno Gonzalez-Zorn
Bruno Gonzalez-Zorn
Arm/Rmt methyltransferases have emerged recently in pathogenic bacteria as enzymes that confer high-level resistance to 4,6-disubstituted aminoglycosides through methylation of the G1405 residue in the 16S rRNA (like ArmA and RmtA to -E). In prokaryotes, nucleotide methylations are the most common type of rRNA modification, and they are introduced posttranscriptionally by a variety of site-specific housekeeping enzymes to optimize ribosomal function. Here we show that while the aminoglycoside resistance methyltransferase RmtC methylates G1405, it impedes methylation of the housekeeping methyltransferase RsmF at position C1407, a nucleotide that, like G1405, forms part of the aminoglycoside binding pocket of the 16S rRNA. To understand the origin and consequences of this phenomenon, we constructed a series of in-frame knockout and knock-in mutants of Escherichia coli , corresponding to the genotypes rsmF + , Δ rsmF , rsmF + rmtC + , and Δ rsmF rmtC + . When analyzed for the antimicrobial resistance pattern, the Δ rsmF bacteria had a decreased susceptibility to aminoglycosides, including 4,6- and 4,5-deoxystreptamine aminoglycosides, showing that the housekeeping methylation at C1407 is involved in intrinsic aminoglycoside susceptibility in E. coli . Competition experiments between the isogenic E. coli strains showed that, contrary to expectation, acquisition of rmtC does not entail a fitness cost for the bacterium. Finally, matrix-assisted laser desorption ionization (MALDI) mass spectrometry allowed us to determine that RmtC methylates the G1405 residue not only in presence but also in the absence of aminoglycoside antibiotics. Thus, the coupling between housekeeping and acquired methyltransferases subverts the methylation architecture of the 16S rRNA but elicits Arm/Rmt methyltransferases to be selected and retained, posing an important threat to the usefulness of aminoglycosides worldwide.

1 June 2017 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
COCristina M. Ovejero
Cristina M. Ovejero
JEJose Antonio Escudero
Jose Antonio Escudero
DTDaniel Thomas-Lopez
Daniel Thomas-Lopez
AHAndreas Hoefer
Andreas Hoefer
GMGabriel Moyano
Gabriel Moyano
BGBruno Gonzalez-Zorn
Bruno Gonzalez-Zorn
In this study, we characterized two tigecycline-resistant Klebsiella pneumoniae isolates from dog urine samples. The isolates were genetically unrelated, belonging to sequence type 11 (ST11) and ST147, both classically related to human isolates. To the best of our knowledge, this is the first identification of tigecycline-resistant isolates from animals. We unveil here the worrisome circulation among animals of bacterial clones resistant to this last-resort antibiotic.

1 May 2019 in EFSA Supporting Publications
Verified
Journal Article
Open access
PDF file
E(European Centre For Disease Control (Ecdc)
European Centre For Disease Control (Ecdc)
IWIvo Van Walle
Ivo Van Walle
BGBeatriz Guerra
Beatriz Guerra
VBVítor Borges
Vítor Borges
JCJoão André Carriço
João André Carriço
VCVincenzo Cavalieri
Vincenzo Cavalieri
EFSA and ECDC were requested by the European Commission to jointly evaluate the possible solutions for the collection and analysis of whole genome sequencing (WGS) data for at least Listeria monocytogenes, Salmonella and Escherichia coli by: (1) analysing the outcome of the surveys on the status of the use of WGS of food‐borne pathogens in EU/EEA countries in both the food and public health sectors; (2) conducting a consultation of relevant actors to assess state‐of‐the‐art pipelines for collecting and analysing WGS data in Europe; (3) involving relevant stakeholders to assess the needs and requirements for the analysis of WGS data and their comparability; and (4) preparing a technical report on the identification and comparison of potential solutions for the set‐up and running of a joint EFSA‐ECDC pipeline to collect and analyse WGS data. Logical components of the overall system were identified and technical requirements were prioritised and grouped according to functionality. Eleven platforms (solutions) that integrate the relevant functionalities for collecting, analysing and visualising WGS data were thoroughly described. The degree to which the requirements are met by the different solutions (as of 31 December 2018) was evaluated. The assessment made clear that no single solution meets all the critical requirements and each solution has significant gaps regarding the unmet critical requirements. Therefore, scenarios consisting of a combination of several solutions were considered. As there may be many suitable scenarios, and the choice among them will depend on strategic or financial elements that are not within the scope of this report, it contains the scientific and technical elements necessary to generate scenarios, rather proposing individual scenarios. A scenario builder is presented which includes the significant gaps for each solution/functionality and the limitations and risks to be considered when setting up a joint ECDC‐EFSA database for the collection and analysis of WGS data.